Hubungan Dukungan Keluarga Dalam Program Prolanis Dengan Kepatuhan Minum Obat Pasien Diabetes Melitus Tipe 2 Di Puskesmas Rawat Inap Banjarsari Kota Metro Tahun 2019

Vio Nita Gustianto, Muhammad Djakfar Sadiq

Abstract


Abstract

Diabetes mellitus is a chronic metabolic disorder due to the pancreas not producing enough insulin or the body cannot use insulin produced effectively. Metro City ranks 1 in Lampung Province with the number of people with diabetes mellitus. Banjarsari Public Health Center in Metro City has a Prolanis program with 50 people with type 2 diabetes mellitus but only 16 people with type 2 diabetes who measure blood sugar levels with the results of 5 people (31.25%) blood sugar levels> normal and 11 people (68.75 %) blood sugar levels in the normal category. This study uses a cross sectional design from 26 to 31 July 2019 at Banjarsari Community Health Center in Metro City in 2019. The sample of this study was 45 respondents. Data analysis using univariate and bivariate. For bivariate use the chi-test test. The results showed that there was a significant relationship between family involvement in the prolanis program (p value of 0.039) with adherence to take medication for Type 2 Diabetes Mellitus patients at the Banjarsari Community Health Center in Metro City in 2019. From the results of the study it was suggested to be able to invite and include families of people with diabetes mellitus type 2 in providing health care and for people with type 2 diabetes mellitus in order to foster self-awareness to change healthy lifestyles.

Keywords  : Family Involvement, Patient Drug Adherence Compliance

Abstract

Diabetes mellitus is a chronic metabolic disorder due to the pancreas not producing enough insulin or the body cannot use insulin produced effectively. Metro City ranks 1 in Lampung Province with the number of people with diabetes mellitus. Banjarsari Public Health Center in Metro City has a Prolanis program with 50 people with type 2 diabetes mellitus but only 16 people with type 2 diabetes who measure blood sugar levels with the results of 5 people (31.25%) blood sugar levels> normal and 11 people (68.75 %) blood sugar levels in the normal category. This study uses a cross sectional design from 26 to 31 July 2019 at Banjarsari Community Health Center in Metro City in 2019. The sample of this study was 45 respondents. Data analysis using univariate and bivariate. For bivariate use the chi-test test. The results showed that there was a significant relationship between family involvement in the prolanis program (p value of 0.039) with adherence to take medication for Type 2 Diabetes Mellitus patients at the Banjarsari Community Health Center in Metro City in 2019. From the results of the study it was suggested to be able to invite and include families of people with diabetes mellitus type 2 in providing health care and for people with type 2 diabetes mellitus in order to foster self-awareness to change healthy lifestyles..Keywords  : Family Involvement, Patient Drug Adherence Compliance

Full Text:

PDF

References


Alfian, R. 2015. Korelasi antara Kepatuhan Minum Obat dengan Kadar Gula Darah pada Pasien Diabetes Melitus Rawat Jalan di RSUD Dr. H. Moch. Ansari Saleh Banjarmasin. Jurnal Pharmascience. 2(2): 15–23

American Diabetes Association (ADA). (2013). Standards of medical care in diabetes. http://care.diabetesjournals.org/content/36/Supplement_1/S11.full.pdf.

Anggita. 2015. Hubungan Antara Dukungan Pasangan Terhadap Kepatuhan Diet Pada Penderita Diabetes Melitus Tipe 2 Di Wilayah Kerja Puskesmas Munjul. Jakarta. Skripsi Universitas Islam Negeri Syarif Hidayatullah

Balitbang Kemenkes RI. 2018. Riset Kesehatan Dasar; RISKESDAS. Jakarta: Balitbang Kemenkes RI

Berkat dkk, (2018), Faktor-Faktor Yang Berhubungan Dengan Kadar Gula Darah Pada Penderita Diabetes Melitus Tipe 2 DI RSUD K.R.M.T Wongsonegoro Semarang. Diakses di alamat https://ejournal3.undip.ac.id/index.php/jkm/article/viewFile/19866/18783

Bianchi, C., Miccoli, R., Daniele, G., Penno, G., & Del Prato, S. (2009). Is there evidence that oral hypoglycemic agents reduce cardiovascular morbidity/mortality? Yes. Diabetes care, 32(suppl 2), S342-S348.

Bilous, Rudy dan Donelly, Richard. 2014. Buku Pegangan Diabetes. Jakarta :Bumi Medika

BPJS. 2019. panduan praktis PROLANIS (Program Pengelolaan Penyakit Kronis). Jakarta. BPJS

Decroli. 2019. Diabetes Militus Tipe 2. Palembang. Pusat Penerbitan Bagian Ilmu Penyakit Dalam

Green, Lawrence. 2005. Health Education Planning A Diagnostic Approach. Baltimore. The John Hopkins University, Mayfield Publishing Co,

Idris, F. (2014). Pengintegrasian Program Preventif Penyakit Diabetes Melitus Tipe 2 PT Askes (Persero) ke Badan Penyelenggara Jaminan Sosial Kesehatan (BPJS Kesehatan). Journal of The Indonesia Medical Association, 64(3).

Isworo, (2016). Hubungan Antara Dukungan Keluarga Dengan Kadar Glukosa Darah Pasien Dm Tipe 2 Di RSUD Sragen. Diakses dialamat https://jurnal.unimus.ac.id/index.php/psn12012010/article/view/312

Joyce danJane. 2014. Buku Ajar Keperawatan Medikal Bedah Edisi 8 Jilid 2. Elsevier: Salemba Medika

Kurniadi, Helmanu dan Nurrahmani, Ulfa. 2014. Stop Diabetes Hipertensi Kolesterol Tinggi Jantung Koroner. Yogyakarta: Istana Medika

Laoh dkk. 2013. Hubungan Dukungan Keluarga Dengan Kepatuhan Minum Obat Pada Penderita Diabetes Mellitus Tipe 2 Di Poli Endokrin BLU RSU Prof. Dr. R. D. Kandou. Manado. Jurnal

Marinda. 2016. Tatalaksana Farmakologi Diabetes Militus Tipe 2 Pada Wanita Lansia dengan Kadar Gula Tidak Normal. Lampung. Jurnal Fakultas Kedokteran Universitas Lampung

Oktaviani dkk. 2018. Faktor Yang Berhubungan Dengan Kepatuhan Penderita Diabetes Mellitus Tipe 2 Dalam Minum Obat Di Puskesmas Pudak Payung Kota Semarang. Semarang. Jurnal

Perkeni, P. E. I. (2011). Konsensus Pengendalian dan Pencegahan Diabetes Melitus Tipe 2 di Indonesia (The Consensus of Control and Prevention of Type 2 Diabetes Mellitus).Jakarta: Perkeni (Indonesian Society of Endocrinology).

Prihaningtyas, R. 2013. Hidup Manis Dengan Diabetes.Yogyakarta : Media Pressindo

Riskesdas RI. 2018. Profil Riset Kesehatan Dasar Tahun 2018. Jakarta. Reskesdas RI

Shaw JE, Sicree RA, Zimmet PZ. 2010. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes research and clinical practice 87. p 4–14. Diakses dialamat www.elsevier.com/locate/diabres.

Soelistijo. 2015. Pengolahan dan Pencegahan Diabetes Militus Tipe 2 Di Indonesia. Jakarta. Perkeni

Soeryoko, Hery. 2011. 25 TanamanObatAmpuhPenakluk Diabetes Melitus. Yogyakarta: ANDI

Srikartika dkk. 2014. Analisis Faktor – Faktor Yang Mempengaruhi Kepatuhan Penggunaan Obat Pasien Diabetes Tipe 2. Kalimantan Selatan. Jurnal

Syamsiah, Nur. 2017.Berdama Dengan Diabetes. Jakarta: Tim BukuMedika

Yunir, E., & Purnamasari, D. (2014). The Indonesian society of endocrinology’s summary article of diabetes mellitus national clinical practice guidelines. Journal of the ASEAN Federation of Endocrine Societies, 26(1), 17.

Yusra. 2011. Hubungan dukungan keluarga dengan Kepatuhan Penggunaan Obat Pasien Diabetes Tipe 2. Jakarta. Skripsi Uneversitas Indonesia




DOI: https://doi.org/10.57084/jikmi.v1i1.301

Refbacks

  • There are currently no refbacks.